An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects
Clinical trial NCT00811564 · COMPLETED
Trial details
- NCT number
- NCT00811564
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2010-01-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.